Differences in survival between colon and rectal cancer from SEER data

Area of Science:

• Epidemiology
• Oncology
• Cancer Research

Background:

• Colorectal cancer encompasses both colon and rectal cancers, but their distinct features remain unclear.
• Understanding differences is crucial for accurate diagnosis and treatment strategies.

Purpose of the Study:

• To compare the epidemiological features and survival outcomes of colon cancer versus rectal cancer.
• Utilize recent national cancer surveillance data for a comprehensive analysis.

Main Methods:

• Analysis of a large cohort (372,130 patients) from the Surveillance, Epidemiology, and End Results (SEER) Program (1995-2008).
• Focus on adenocarcinoma subtype of colorectal cancer.
• Evaluation of mean survival rates across different stages for colon and rectal cancer patients.

Main Results:

• Survival varied by stage: colon cancer showed better survival in stage IIB (by 4 months), while rectal cancer had better survival in stages IIIC and IV (by 3 months).
• Stage IIB colorectal cancer demonstrated a poorer prognosis compared to stages IIIA and IIIB.
• After adjusting for demographics, these stage-specific survival differences between colon and rectal cancer persisted.

Conclusions:

• Rectal cancer prognosis is comparable to colon cancer.
• Locally advanced colorectal cancer with lymph node metastasis has a poorer prognosis.
• Stage IIB colorectal cancer may warrant more aggressive chemotherapy, similar to stage III treatments.